At a glance
ClinicalIndex Comparison Record- ✓Recently confirmed unilateral ductal carcinoma in situ or invasive breast cancer, confirmed by biopsy or FNA within past 60 days
- ✓Negative or benign mammogram (BI-RADS 1 or 2) and negative/benign clinical breast exam of contralateral breast within past 90 days
- ✓Age 18 years or older
- ✓Female sex
- ✕Remote history of breast cancer
- ✕New breast symptoms within past 60 days for which further evaluation is recommended
- ✕Pacemaker or magnetic aneurysm clips
- ✕Implanted magnetic device
Standardized by ClinicalIndex from the ClinicalTrials.gov record · verify against the source.
MRI Evaluation Of The Contralateral Breast In Women With Recent Diagnosis Of Breast Cancer
In Brief
A clinical study evaluating MRI for Breast Cancer and Contralateral Breast Cancer. Completed, enrolled 1,007 participants across 21 sites in 3 countries.
Detailed Summary
RATIONALE: Diagnostic procedures such as magnetic resonance imaging (MRI) may improve the ability to detect cancer in the unaffected breast of women recently diagnosed with unilateral breast cancer. PURPOSE: Diagnostic trial to determine the effectiveness of MRI in evaluating the unaffected breast of women recently diagnosed with unilateral breast cancer.
Study Details
Timeline
Interventions
Breast contralateral to the breast diagnosed with cancer was scanned prior to initiation of chemotherapy and within 90 days of a negative mammogram of the study breast. A recent (within 90 days) negative or benign mammogram (defined by final BI RADS category 1 or 2) and negative or benign clinical breast exam of the study breast were required for entry into the study.